• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胆固醇合成与磷酸戊糖途径之间的正反馈而不是糖酵解促进了肝细胞癌。

A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinoma.

机构信息

School of Pharmacy, Hubei University of Chinese Medicine, Wuhan, PR China.

Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, 55455, USA.

出版信息

Oncogene. 2023 Sep;42(39):2892-2904. doi: 10.1038/s41388-023-02757-9. Epub 2023 Jun 26.

DOI:10.1038/s41388-023-02757-9
PMID:37596320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10516751/
Abstract

Hepatic cholesterol accumulation and hypercholesterolemia are implicated in hepatocellular carcinoma (HCC). However, the therapeutic effects of cholesterol-lowering drugs on HCC are controversial, indicating that the relationship between cholesterol metabolism and HCC is more complex than anticipated. A positive feedback between cholesterol synthesis and the pentose phosphate pathway (PPP) rather than glycolysis was formed in tumors of c-Myc mice. Blocking the PPP prevented cholesterol synthesis and thereby HCC in c-Myc mice, while ablating glycolysis did not affect cholesterol synthesis and failed to prevent c-Myc-induced HCC. Unexpectedly, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) and G6PD (glucose-6-phosphate dehydrogenase), the rate-limiting enzymes of cholesterol synthesis and the PPP, were identified as direct targets of microRNA-206. By targeting Hmgcr and G6pd, microRNA-206 disrupted the positive feedback and fully prevented HCC in c-Myc mice, while 100% of control mice died of HCC. Disrupting the interaction of microRNA-206 with Hmgcr and G6pd restored cholesterol synthesis, the PPP and HCC growth that was inhibited by miR-206. This study identified a previously undescribed positive feedback loop between cholesterol synthesis and the PPP, which drives HCC, while microRNA-206 prevents HCC by disrupting this loop. Cholesterol synthesis as a process rather than cholesterol itself is the major contributor of HCC.

摘要

肝内胆固醇积累和高胆固醇血症与肝细胞癌(HCC)有关。然而,降脂药物对 HCC 的治疗效果存在争议,这表明胆固醇代谢与 HCC 之间的关系比预期的更为复杂。c-Myc 小鼠肿瘤中形成了胆固醇合成与戊糖磷酸途径(PPP)之间而不是糖酵解之间的正反馈。阻断 PPP 可防止胆固醇合成并因此阻止 c-Myc 小鼠的 HCC,而糖酵解的缺失不会影响胆固醇合成并且不能阻止 c-Myc 诱导的 HCC。出乎意料的是,胆固醇合成和 PPP 的限速酶 HMGCR(3-羟-3-甲基戊二酰辅酶 A 还原酶)和 G6PD(葡萄糖-6-磷酸脱氢酶)被鉴定为 microRNA-206 的直接靶标。通过靶向 Hmgcr 和 G6pd,microRNA-206 破坏了正反馈并完全阻止了 c-Myc 小鼠的 HCC,而 100%的对照小鼠死于 HCC。破坏 microRNA-206 与 Hmgcr 和 G6pd 的相互作用恢复了被 miR-206 抑制的胆固醇合成、PPP 和 HCC 生长。这项研究确定了胆固醇合成与 PPP 之间以前未描述的正反馈环,该环驱动 HCC,而 microRNA-206 通过破坏该环来预防 HCC。胆固醇合成作为一个过程而不是胆固醇本身是 HCC 的主要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/233b1160c5e3/41388_2023_2757_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/d6774c48c081/41388_2023_2757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/d5f112734695/41388_2023_2757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/55edd30171f6/41388_2023_2757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/994f1a069afa/41388_2023_2757_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/eea5a801a130/41388_2023_2757_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/da60ab13f254/41388_2023_2757_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/8a682cefcfcd/41388_2023_2757_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/233b1160c5e3/41388_2023_2757_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/d6774c48c081/41388_2023_2757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/d5f112734695/41388_2023_2757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/55edd30171f6/41388_2023_2757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/994f1a069afa/41388_2023_2757_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/eea5a801a130/41388_2023_2757_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/da60ab13f254/41388_2023_2757_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/8a682cefcfcd/41388_2023_2757_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01d6/10516751/233b1160c5e3/41388_2023_2757_Fig8_HTML.jpg

相似文献

1
A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinoma.胆固醇合成与磷酸戊糖途径之间的正反馈而不是糖酵解促进了肝细胞癌。
Oncogene. 2023 Sep;42(39):2892-2904. doi: 10.1038/s41388-023-02757-9. Epub 2023 Jun 26.
2
ID1 promotes hepatocellular carcinoma proliferation and confers chemoresistance to oxaliplatin by activating pentose phosphate pathway.ID1 通过激活戊糖磷酸途径促进肝癌细胞增殖并赋予奥沙利铂耐药性。
J Exp Clin Cancer Res. 2017 Nov 23;36(1):166. doi: 10.1186/s13046-017-0637-7.
3
Glutaryl-CoA dehydrogenase suppresses tumor progression and shapes an anti-tumor microenvironment in hepatocellular carcinoma.谷氨酰辅酶 A 脱氢酶抑制肝癌的肿瘤进展并塑造抗肿瘤微环境。
J Hepatol. 2024 Nov;81(5):847-861. doi: 10.1016/j.jhep.2024.05.034. Epub 2024 May 31.
4
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma.肝细胞癌的代谢失调与新兴治疗靶点
Acta Pharm Sin B. 2022 Feb;12(2):558-580. doi: 10.1016/j.apsb.2021.09.019. Epub 2021 Sep 25.
5
A feedback loop of PPP and PI3K/AKT signal pathway drives regorafenib-resistance in HCC.PPP与PI3K/AKT信号通路的反馈回路驱动肝癌对瑞戈非尼产生耐药性。
Cancer Metab. 2023 Dec 18;11(1):27. doi: 10.1186/s40170-023-00311-5.
6
Loss of miR-192-5p initiates a hyperglycolysis and stemness positive feedback in hepatocellular carcinoma.miR-192-5p 的缺失会在肝癌中引发高糖酵解和干性正反馈。
J Exp Clin Cancer Res. 2020 Nov 30;39(1):268. doi: 10.1186/s13046-020-01785-7.
7
PTEN antagonises Tcl1/hnRNPK-mediated G6PD pre-mRNA splicing which contributes to hepatocarcinogenesis.PTEN 拮抗 Tcl1/hnRNPK 介导的 G6PD 前体 mRNA 剪接,从而促进肝癌发生。
Gut. 2014 Oct;63(10):1635-47. doi: 10.1136/gutjnl-2013-305302. Epub 2013 Dec 18.
8
The role of miR-122 in the dysregulation of glucose-6-phosphate dehydrogenase (G6PD) expression in hepatocellular cancer.miR-122 在肝细胞癌中葡萄糖-6-磷酸脱氢酶(G6PD)表达失调中的作用。
Sci Rep. 2018 Jun 14;8(1):9105. doi: 10.1038/s41598-018-27358-5.
9
Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.慢性乙型和丙型肝炎及肝癌的转录组分析揭示了microRNA介导的胆固醇合成程序调控。
mBio. 2015 Dec 8;6(6):e01500-15. doi: 10.1128/mBio.01500-15.
10
Integrated analyses identify miR-34c-3p/MAGI3 axis for the Warburg metabolism in hepatocellular carcinoma.整合分析确定 miR-34c-3p/MAGI3 轴在肝癌的沃伯格代谢中的作用。
FASEB J. 2020 Apr;34(4):5420-5434. doi: 10.1096/fj.201902895R. Epub 2020 Feb 20.

引用本文的文献

1
Mechanism and therapeutic potential of liver injury induced by cholesterol-associated proteins.胆固醇相关蛋白诱导肝损伤的机制及治疗潜力
Front Pharmacol. 2025 Mar 27;16:1572592. doi: 10.3389/fphar.2025.1572592. eCollection 2025.
2
The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers.磷酸戊糖途径:从机制到对胃肠道癌症的影响
Int J Mol Sci. 2025 Jan 13;26(2):610. doi: 10.3390/ijms26020610.
3
Mevalonate kinase inhibits anti-tumor immunity by impairing the tumor cell-intrinsic interferon response in microsatellite instability colorectal cancer.

本文引用的文献

1
Statins were not associated with hepatocellular carcinoma after controlling for time-varying confounders in patients with diabetes.在对糖尿病患者的时变混杂因素进行控制后,他汀类药物与肝细胞癌无关。
J Clin Epidemiol. 2022 Oct;150:98-105. doi: 10.1016/j.jclinepi.2022.06.014. Epub 2022 Jun 30.
2
Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma.胆固醇代谢:肝细胞癌中的一把双刃剑
Front Cell Dev Biol. 2021 Nov 10;9:762828. doi: 10.3389/fcell.2021.762828. eCollection 2021.
3
MicroRNA-206 enhances antitumor immunity by disrupting the communication between malignant hepatocytes and regulatory T cells in c-Myc mice.
甲羟戊酸激酶通过损害微卫星不稳定型结直肠癌中肿瘤细胞内在的干扰素反应来抑制抗肿瘤免疫。
Oncogene. 2025 Apr;44(14):944-957. doi: 10.1038/s41388-024-03255-2. Epub 2024 Dec 26.
4
Loss of Carbamoyl Phosphate Synthetase 1 Potentiates Hepatocellular Carcinoma Metastasis by Reducing Aspartate Level.氨甲酰磷酸合成酶1缺失通过降低天冬氨酸水平增强肝细胞癌转移。
Adv Sci (Weinh). 2024 Dec;11(45):e2402703. doi: 10.1002/advs.202402703. Epub 2024 Oct 10.
5
Crosstalk between Epigenetics and Metabolic Reprogramming in Metabolic Dysfunction-Associated Steatotic Liver Disease-Induced Hepatocellular Carcinoma: A New Sight.代谢功能障碍相关脂肪性肝病诱导的肝细胞癌中表观遗传学与代谢重编程之间的串扰:新视角
Metabolites. 2024 Jun 8;14(6):325. doi: 10.3390/metabo14060325.
6
MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in mice.miR-206 作为一种有潜力的降胆固醇药物,在降低胆固醇方面优于他汀类药物。
J Lipid Res. 2024 Jul;65(7):100576. doi: 10.1016/j.jlr.2024.100576. Epub 2024 Jun 10.
7
Pivotal role of intestinal cholesterol and nuclear receptor LXR in metabolic liver steatohepatitis and hepatocarcinoma.肠道胆固醇和核受体肝X受体在代谢性肝脂肪性肝炎和肝癌中的关键作用
Cell Biosci. 2024 Jun 1;14(1):69. doi: 10.1186/s13578-024-01248-y.
miR-206 通过破坏 c-Myc 小鼠中恶性肝细胞与调节性 T 细胞之间的通讯来增强抗肿瘤免疫。
Hepatology. 2022 Jul;76(1):32-47. doi: 10.1002/hep.32182. Epub 2021 Nov 22.
4
LDLR inhibition promotes hepatocellular carcinoma proliferation and metastasis by elevating intracellular cholesterol synthesis through the MEK/ERK signaling pathway.LDLR 抑制通过 MEK/ERK 信号通路升高细胞内胆固醇合成,促进肝细胞癌增殖和转移。
Mol Metab. 2021 Sep;51:101230. doi: 10.1016/j.molmet.2021.101230. Epub 2021 Apr 3.
5
MYC Enhances Cholesterol Biosynthesis and Supports Cell Proliferation Through SQLE.MYC通过SQLE增强胆固醇生物合成并支持细胞增殖。
Front Cell Dev Biol. 2021 Mar 11;9:655889. doi: 10.3389/fcell.2021.655889. eCollection 2021.
6
Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.胆固醇水平升高而非他汀类药物的使用与肝细胞癌风险降低有关。
Br J Cancer. 2020 Mar;122(5):630-633. doi: 10.1038/s41416-019-0691-3. Epub 2019 Dec 20.
7
Statin use and risk of liver cancer: Evidence from two population-based studies.他汀类药物的使用与肝癌风险:来自两项基于人群的研究证据。
Int J Cancer. 2020 Mar 1;146(5):1250-1260. doi: 10.1002/ijc.32426. Epub 2019 Jun 4.
8
Crucial role of the pentose phosphate pathway in malignant tumors.磷酸戊糖途径在恶性肿瘤中的关键作用。
Oncol Lett. 2019 May;17(5):4213-4221. doi: 10.3892/ol.2019.10112. Epub 2019 Mar 5.
9
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens.CRISPOR:用于 CRISPR/Cas9 基因组编辑实验和筛选的直观向导选择。
Nucleic Acids Res. 2018 Jul 2;46(W1):W242-W245. doi: 10.1093/nar/gky354.
10
Clinicopathological and prognostic significance of OCT4 in patients with hepatocellular carcinoma: a meta-analysis.OCT4在肝细胞癌患者中的临床病理特征及预后意义:一项荟萃分析
Onco Targets Ther. 2017 Dec 21;11:47-57. doi: 10.2147/OTT.S151390. eCollection 2018.